Objective {#Sec1}
=========

The expression of the fragile histidine triad gene, *FHIT*, is lost in over half of human cancers \[[@CR1]\]. Because Fhit is a cytoplasmic protein with few interacting protein partners, finding both the mechanism and downstream effectors of Fhit genome protective and tumor suppressor activities have been challenging \[[@CR1], [@CR2]\]. Early experiments to characterize the enzymatic function(s) of Fhit showed that Fhit binds and cleaves diadenosine triphosphate (ApppA) and other dinucleoside triphosphates in vitro \[[@CR3], [@CR4]\]. The ApppA molecules are very similar to free cap dinucleotides (m7GpppN). All mRNAs receive a 5′ cap consisting of 7-methylguanosine linked to the first transcribed nucleotide through a 5′, 5′ triphosphate linkage. Cap dinucleotides are generated as end-products of the 3′--5′ RNA decay pathway. In normal cells free cap dinucleotides are degraded by scavenger decapping enzymes \[[@CR5]\]. Interestingly, Fhit has been shown to bind and hydrolyze cap dinucleotides in vitro \[[@CR6]\]. The subsequent discovery that Fhit and its yeast homolog Aph1 exhibit scavenger decapping activity, at least in vitro, suggests a mechanism through which it may act as a tumor suppressor and genome caretaker, and may be key to identifying additional downstream effectors \[[@CR7]\]. We tested the hypothesis that Fhit regulates cancer linked mRNAs at the translational level. Our initial work showing that TK1 protein expression is translationally controlled by Fhit is consistent with a scavenger decapping-based regulatory mechanism \[[@CR8]\]. The current study used RNA-Seq, polysome profiling and mRNA turnover analysis to identify Fhit-mediated changes in additional cancer-linked mRNAs. This laid the foundation for a subsequent study to identify the transcriptome-wide impact of *FHIT* loss on translation \[[@CR9]\]. In the latter study ribosome profiling and an independent set of sample-matched RNA-Seq data were used to identify Fhit-mediated changes in ribosome occupancy.

Data description {#Sec2}
================

The data in this submission come from three different experiments. The first experiment (Data files 1 and 2) is an RNA-Seq gene expression study to characterize global Fhit-mediated changes in gene expression in cytoplasmic RNA harvested from H1299 lung cancer cells where Fhit is expressed or silenced. With a padj significance threshold of \< 0.05, the RNA-Seq libraries yielded \~ 900 mRNAs with levels of detection differing in cytoplasm by at least 1.5-fold (Data file 2) in Fhit positive vs. Fhit negative H1299 cells.

Next, we assessed the translation of several newly identified Fhit-affected mRNAs using cDNAs remaining from earlier cytoplasmic polysome gradient fractionation experiments \[[@CR8]\]. Polysome gradient fractionation separates protein-RNA complexes based on their mass, and can approximate the translational output of an mRNA based on the number of ribosomes loaded onto it. A total of ten mRNAs, two controls (Rplp0 and PolR2A), and eight cancer-linked mRNAs (ATF6, GDF15, CENPH, CSK1B, SPC25, AURKA, NDC80, and Top2A) were selected from our RNA-Seq data and assessed for changes in translation. The resulting data are presented in Data files 3, 4, and 5 (Table [1](#Tab1){ref-type="table"}).Table 1Overview of data files/data setsLabelName of data file/data setFile types (file extension)Data repository and identifier (DOI or accession number)Data set 1RNA-Seq FASTQ files generated from RNA sequencingFASTQ files\[[@CR10]\] <https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP124332>Data file 2Changes in mRNA levels upon Fhit rescue as assayed by RNA-SeqMS Excel file (.xlsx)\[[@CR11]\] <http://dx.doi.org/10.6084/m9.figshare.5539123>Data file 3Polysome gradient analysis of translational changes in response to Fhit lossAdobe acrobat file (.pdf)\[[@CR12]\] <http://dx.doi.org/10.6084/m9.figshare.5540473>Data file 4Numerical qPCR values and calculations for Data file 3MS Excel file (.xlsx)\[[@CR13]\] <http://dx.doi.org/10.6084/m9.figshare.5877033>Data file 5Quantifying changes in ribosome occupancy when Fhit expression is lostAdobe acrobat file (.pdf)\[[@CR14]\] <http://dx.doi.org/10.6084/m9.figshare.5540146>Data file 6Assaying changes in mRNA stability in response to Fhit lossAdobe acrobat file (.pdf)\[[@CR15]\] <http://dx.doi.org/10.6084/m9.figshare.5540476>Data file 7Numerical qPCR values and calculations for Data file 6MS Excel file (.xlsx)\[[@CR16]\] <http://dx.doi.org/10.6084/m9.figshare.5877027>Data file 8The methods used for the experiments and data analysisAdobe acrobat file (.pdf)\[[@CR17]\] <http://dx.doi.org/10.6084/m9.figshare.5540482>

Finally, we determined if Fhit expression altered the stability of the mRNAs studied. Briefly, cells were treated with 5,6-dichloro-1-β-[d]{.smallcaps}-ribofuranosylbenzimidazole (DRB), a selective inhibitor of RNA polymerase II, for 0--10 h. RNA was harvested from cytoplasmic extracts at 2 h intervals after DRB treatment began. Fhit-dependent changes in the stability of targeted mRNAs was assayed using RT-qPCR and are reported in Data files 6 and 7.

A detailed description of the methods used to gather and analyze these data is provided in Data file 6.

Limitations {#Sec3}
===========

The key limitation of this study is the small cross section of mRNAs assayed. Of the \~ 900 mRNAs that changed ≥ 1.5-fold in response to Fhit loss, we assessed 10, two controls and eight mRNAs whose gene products were known to be involved in cancer-linked processes. Since our previous work showed that Fhit affects the translation of TK1 mRNA \[[@CR8]\] we assayed these 10 mRNAs for effects on translation and mRNA stability. Ideally, we would have assayed more targets. The second limitation was the behavior of our two control mRNAs in the polysome gradient experiments. Namely, the translation rates of our control mRNAs (RPLP0 and POLR2A) change when Fhit is lost. Although the behavior of an ideal control would not change with respect to Fhit levels, this result is actually predicted by our hypothesis of how Fhit mediates its translational control functions as a function of its scavenger decapping activity.
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